XpresSpa Group and United Airlines Announce the Opening of an XpresCheck™ COVID-19 Testing Facility at Houston George Bush Intercontinental Airport
Located Post-Security, Terminal E, Operated by United Airlines
First XpresCheck in the
XpresCheck’s pop-up testing facility is located in United’s Terminal E post-security. It has four separate testing rooms and an anticipated capacity to administer over 300 tests per day. COVID-19 testing options include the Rapid Molecular Test and the Polymerase Chain Reaction (PCR) Test.
“Offering accessible and dependable testing solutions provides peace of mind to travelers and facilitates a safer in-flight experience,” said
About
Twitter: @xprescheck and Instagram: @realxprescheck
About United Airlines
United's shared purpose is "Connecting People. Uniting the World." For more information, visit united.com, follow @United on Twitter and Instagram or connect on Facebook. The common stock of United's parent, United Airlines Holdings, Inc., is traded on the Nasdaq under the symbol "UAL".
Forward-Looking Statements
Forward-Looking Statements This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations as they become available, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our ability further expand our initial sites and our overall ability to manage the regulatory challenges associated with this business line. Forward-looking statements relating to expectations about future results or events are based upon information available to
Investor Relations:
ICR
ir@xpresspagroup.com
(203) 682-8253
Media:
Julie@jfprmedia.com
(312) 385-0098
United Airlines
david.d.gonzalez@united.com
832-671-8707
Source: XpresSpa Group, Inc.